A comprehensive genotype-phenotype interaction of different Toll-like receptor variations in a renal transplant cohort

Clinical Science

Volumn 119, Issue 12, 2010, Pages 535-544

  Krüger, Bernd ^a,b   Banas, Miriam C ^b   Walberer, Andreas ^b   Böger, Carsten A ^b   Farkas, Stefan ^b   Hoffmann, Ute ^b   Fischereder, Michael ^c   Banas, Bernhard ^b   Krämer, Bernhard K ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Acute rejection; Cardiovascular morbidity; Polymorphism; Renal transplantation; Toll like receptor (TLR)

Indexed keywords

CD14 ANTIGEN; GAMMA INTERFERON; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9;

ACUTE HEART FAILURE; ADULT; ALLELE; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CYTOMEGALOVIRUS INFECTION; DELAYED GRAFT FUNCTION; GENE INTERACTION; GENOTYPE; GRAFT SURVIVAL; HEART INFARCTION; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MALIGNANT VENTRICULAR ARRHYTHMIA; MORBIDITY; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; URINARY TRACT INFECTION;

ADULT; AGED; CARDIOVASCULAR DISEASES; EPIDEMIOLOGIC METHODS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; TOLL-LIKE RECEPTORS;

EID: 78649857656     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20100190     Document Type: Article

References (43)

1. Wu, O., Levy, A. R., Briggs, A., Lewis, G. and Jardine, A. (2009) Acute rejection and chronic nephropathy: a systematic review of the literature. Transplantation 87, 1330-1339
2. Marcén, R. (2009) Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection. Drugs 69, 2227-2243
3. Hansson, G. K. (2005) Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685-1695
4. Alegre, M. L., Leemans, J., Le Moine, A., Florquin, S., De Wilde, V., Chong, A. and Goldman, M. (2008) The multiple facets of Toll-Like receptors in transplantation biology. Transplantation 86, 1-9
5. Krüger, B., Schröppel, B. and Murphy, B. T. (2008) Genetic polymorphisms and the fate of the transplanted organ. Transplant. Rev. 22, 131-140
6. Krüger, B., Böger, C. A., Schröppel, B., Obed, A., Hoffmann, U., Murphy, B. T., Fischereder, M., Holler, E., Banas, B. and Krämer, B. K. (2007) Impact of NOD2/CARD15 haplotypes on the outcome after kidney transplantation. Transplant. Int. 20, 600-607
7. Curtiss, L. K. and Tobias, P. S. (2009) Emerging role of Toll-like receptors in atherosclerosis. J. Lipid Res. 50, (Suppl.), S340-S345
8. Kiechl, S., Lorenz, E., Reindl, M., Wiedermann, C. J., Oberhollenzer, F., Bonora, E., Willeit, J. and Schwartz, D. A. (2002) Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 347, 185-192
9. Kazemi, M. R., McDonald, C. M., Shigenaga, J. K., Grunfeld, C. and Feingold, K. R. (2005) Adipocyte fatty acid-binding protein expression and lipid accumulation are increased during activation of murine macrophages by toll-like receptor agonists. Arterioscler. Thromb. Vasc. Biol. 25, 1220-1224
10. Krüger, B., Krick, S., Dhillon, N., Lerner, S. M., Ames, S., Bromberg, J. S., Lin, M., Walsh, L., Vella, J., Fischereder, M. et al. (2009) Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc. Natl. Acad. Sci. U.S.A. 106, 3390-3395
11. Huang, Y., Yin, H., Han, J., Huang, B., Xu, J., Zheng, F., Tan, Z., Fang, M., Rui, L., Chen, D. et al. (2007) Extracellular HMGB1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection. Am. J. Transplant. 7, 799-808
12. Ducloux, D., Deschamps, M., Yannaraki, M., Ferrand, C., Bamoulid, J., Saas, P., Kazory, A., Chalopin, J. M. and Tiberghien, P. (2005) Relevance of Toll-like receptor-4 polymorphisms in renal transplantation. Kidney Int. 67, 2454-2461 (Pubitemid 41623410)
13. Palmer, S. M., Burch, L. H., Davis, R. D., Herczyk, W. F., Howell, D. N., Reinsmoen, N. L. and Schwartz, D. A. (2003) The role of innate immunity in acute allograft rejection after lung transplantation. Am. J. Respir. Crit. Care Med. 168, 628-632
14. Palmer, S. M., Burch, L. H., Trindade, A. J., Davis, R. D., Herczyk, W. F., Reinsmoen, N. L. and Schwartz, D. A. (2005) Innate immunity influences long-term outcomes after human lung transplant. Am. J. Respir. Crit. Care Med. 171, 780-785
15. Lorenz, E., Schwartz, D. A., Martin, P. J., Gooley, T., Lin, M. T., Chien, J.W., Hansen, J. A. and Clark, J. G. (2001) Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 7, 384-387
16. Bochud, P. Y., Chien, J. W., Marr, K. A., Leisenring, W. M., Upton, A., Janer, M., Rodrigues, S. D., Li, S., Hansen, J. A., Zhao, L. P. et al. (2008) Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N. Engl. J. Med. 359, 1766-1777
17. Noguchi, E., Nishimura, F., Fukai, H., Kim, J., Ichikawa, K., Shibasaki, M. and Arinami, T. (2004) An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population. Clin. Exp. Allergy 34, 177-183
18. Perico, N., Cattaneo, D., Sayegh, M. H. and Remuzzi, G. (2004) Delayed graft function in kidney transplantation. Lancet 364, 1814-1827 (Pubitemid 39488068)
19. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 39, S1-S266
20. Schröder, N. W., Hermann, C., Hamann, L., Göbel, U. B., Hartung, T. and Schumann, R. R. (2003) High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR. J. Mol. Med. 81, 368-372
21. Misch, E. A. and Hawn, T. R. (2008) Toll-like receptor polymorphisms and susceptibility to human disease. Clin. Sci. 114, 347-360
22. Shoskes, D. A. and Cecka, J. M. (1998) Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation 66, 1697-1701
23. Leemans, J. C., Stokman, G., Claessen, N., Rouschop, K. M., Teske, G. J., Kirschning, C. J., Akira, S., van der Poll, T.,Weening, J. J. and Florquin, S. (2005) Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J. Clin. Invest. 115, 2894-2903
24. Wu, H., Chen, G., Wyburn, K. R., Yin, J., Bertolino, P., Eris, J. M., Alexander, S. I., Sharland, A. F. and Chadban, S. J. (2007) TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest. 117, 2847-2859
25. Abedini, S., Holme, I., Marz,W.,Weihrauch, G., Fellstrom, B., Jardine, A., Cole, E., Maes, B., Neumayer, H. H., Gronhagen-Riska, C., Ambuhl, P. and Holdaas, H. (2009) Inflammation in renal transplantation. Clin. J. Am. Soc. Nephrol. 4, 1246-1254
26. Krüger, B., Walberer, A., Debler, J., Böger, C. A., Farkas, S., Reinhold, S. W., Obed, A., Schlitt, H. J., Fischereder, M., Banas, B. and Krämer, B. K. (2010) Is inflammation prior to renal transplantation predictive for cardiovascular and renal outcomes? Atherosclerosis 210, 637-642
27. Allam, R., Lichtnekert, J., Moll, A. G., Taubitz, A., Vielhauer, V. and Anders, H. J. (2009) Viral RNA and DNA trigger common antiviral responses in mesangial cells. J. Am. Soc. Nephrol. 20, 1986-1996
28. Anders, H. J., Banas, B. and Schlöndorff, D. (2004) Signaling danger: toll-like receptors and their potential roles in kidney disease. J. Am. Soc. Nephrol. 15, 854-867
29. Re, F. and Strominger, J. L. (2004) IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. J. Immunol. 173, 7548-7555
30. Krüger, B., Böger, C. A., Obed, A., Farkas, S., Hoffmann, U., Banas, B., Fischereder, M. and Krämer, B. K. (2007) RANTES/CCL5 polymorphisms as a risk factor for recurrent acute rejection. Clin. Transplant. 21, 385-390
31. Tatapudi, R. R., Muthukumar, T., Dadhania, D., Ding, R., Li, B., Sharma, V. K., Lozada-Pastorio, E., Seetharamu, N., Hartono, C., Serur, D., Seshan, S. V. et al. (2004) Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int. 65, 2390-2397
32. Askar, E., Bregadze, R., Mertens, J., Schweyer, S., Rosenberger, A., Ramadori, G. and Mihm, S. (2009) TLR3 gene polymorphisms and liver disease manifestations in chronic hepatitis C. J. Med. Virol. 81, 1204-1211
33. Hwang, Y. H., Ro, H., Choi, I., Kim, H., Oh, K. H., Hwang, J. I., Park, M. H., Kim, S., Yang, J. and Ahn, C. (2009) Impact of polymorphisms of TLR4/CD14 and TLR3 on acute rejection in kidney transplantation. Transplantation 88, 699-705
34. Krämer, B. K., Böger, C., Krüger, B., Marienhagen, J., Pietrzyk, M., Obed, A., Paczek, L., Mack,M. and Banas, B. (2005) Cardiovascular risk estimates and risk factors in renal transplant recipients. Transplant. Proc. 37, 1868-1870
35. Edfeldt, K., Swedenborg, J., Hansson, G. K. and Yan, Z. Q. (2002) Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105, 1158-1161
36. Edfeldt, K., Bennet, A. M., Eriksson, P., Frostegard, J., Wiman, B., Hamsten, A., Hansson, G. K., de Faire, U. and Yan, Z. Q. (2004) Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. Eur. Heart J. 25, 1447-1453
37. Hernesniemi, J. A., Raitakari, O. T., Kahonen, M., Juonala, M., Hutri-Kahonen, N., Marniemi, J., Viikari, J. and Lehtimaki, T. (2008) Toll-like receptor 4 gene (Asp299Gly) polymorphism associates with carotid artery elasticity. The cardiovascular risk in young Finns study. Atherosclerosis 198, 152-159
38. Hommels, M. J., Kroon, A. A., Netea, M. G., de Leeuw, P.W., Bruggeman, C. A., Leiner, T., Koster, D. A., Stalenhoef, A. F. and van der Ven, A. J. (2007) The Asp299Gly Toll-like receptor 4 polymorphism in advanced aortic atherosclerosis. Neth. J. Med. 65, 203-207
39. Lazarus, R., Klimecki, W. T., Raby, B. A., Vercelli, D., Palmer, L. J., Kwiatkowski, D. J., Silverman, E. K., Martinez, F. and Weiss, S. T. (2003) Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory casecontrol disease association studies. Genomics 81, 85-91
40. Novak, N., Yu, C. F., Bussmann, C., Maintz, L., Peng, W. M., Hart, J., Hagemann, T., Diaz-Lacava, A., Baurecht, H. J., Klopp, N. et al. (2007) Putative association of a TLR9 promoter polymorphism with atopic eczema. Allergy 62, 766-772
41. Hamann, L., Glaeser, C., Hamprecht, A., Gross, M., Gomma, A. and Schumann, R. R. (2006) Toll-like receptor (TLR)-9 promotor polymorphisms and atherosclerosis. Clin. Chim. Acta 364, 303-307
42. Schröder, N. W. and Schumann, R. R. (2005) Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect. Dis. 5, 156-164
43. Hamann, L., Gomma, A., Schröder, N. W., Stamme, C., Glaeser, C., Schulz, S., Gross, M., Anker, S. D., Fox, K. and Schumann, R. R. (2005) A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis. J. Mol. Med. 83, 478-485